Document is current
Any future updates will be listed below
-
Authors
Orozco-Leal, Giovany https://orcid.org/0000-0002-7473-7318
Johnson, Eugenie Evelynne https://orcid.org/0000-0003-3324-7141
Hosseinijebeli, Sedighe https://orcid.org/0000-0001-9448-2685
Robinson, Tomos https://orcid.org/0000-0001-8695-9738
Homer, Tara https://orcid.org/0000-0002-6664-0671
Eastaugh, Claire H. https://orcid.org/0000-0002-1371-6601
Richmond, Catherine https://orcid.org/0000-0002-2940-5197
Tanner, Louise
Meader, Nick
Kenny, Ryan https://orcid.org/0000-0001-9743-4259
Wallace, Sheila A. https://orcid.org/0000-0003-2853-3653
Rice, Stephen https://orcid.org/0000-0002-6767-0813
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR135664)
- License Information
-
More Information
Article History
Accepted: 9 October 2023
First Online: 20 November 2023
Declarations
:
: Ryan Kenny contributed to a technology briefing on this indication for the National Institute for Health and Care Research (NIHR) Innovation Observatory. Giovany Orozco-Leal, Eugenie Evelynne Johnson, Sedighe Hosseinijebeli, Tomos Robinson, Tara Homer, Claire H. Eastaugh, Catherine Richmond, Louise Tanner, Nick Meader, Sheila A Wallace, and Stephen Rice have no conflicts of interest to declare.
: The independent EAG report was commissioned by the NIHR Evidence Synthesis Programme as project number NIHR135664. See the Health Technology Assessment (HTA) programme website for further project information (). This summary of the EAG report was compiled after NICE issued the Final Appraisal Determination. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE or the Department of Health.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design and were involved with the work of the EAG. The manuscript was written by GOL, EEJ, and SR. All authors were involved in the critical review of the clinical and cost-effectiveness evidence, drafting of the EAG report, and providing critical feedback on the manuscript. All authors approved the final version.
